Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - April 2012

The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.

Fampridine (Fampyra®) has been rejected for use to improve walking in adult patients with multiple sclerosis with walking disability. The manufacturer failed to make a submission. The manufacturer already recommends that use is restricted to prescription and supervision by physicians experienced in the management of multiple sclerosis.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - April 2012' on Email Share 'SMC Update - April 2012' on Delicious Share 'SMC Update - April 2012' on Digg Share 'SMC Update - April 2012' on Facebook Share 'SMC Update - April 2012' on Google+ Share 'SMC Update - April 2012' on reddit Share 'SMC Update - April 2012' on StumbleUpon Share 'SMC Update - April 2012' on Twitter

atomic-wealth

No Comments to “SMC Update - April 2012”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,309 spam comments.

atomic-wealth
fond-illness
summer